SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-22-018082
Filing Date
2022-11-18
Accepted
2022-11-18 16:18:15
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20221118xs3.htm S-3 472397
2 EX-4.4 tmb-20221118xex4d4.htm EX-4.4 345262
3 EX-4.6 tmb-20221118xex4d6.htm EX-4.6 357126
4 EX-5.1 tmb-20221118xex5d1.htm EX-5.1 26410
5 EX-23.1 tmb-20221118xex23d1.htm EX-23.1 2398
6 EX-FILING FEES tmb-20221118xexfilingfees.htm EX-FILING FEES 57851
7 GRAPHIC tmb-20221118xex5d1001.jpg GRAPHIC 6097
8 GRAPHIC tmb-20221118xs3001.jpg GRAPHIC 4590
  Complete submission text file 0001558370-22-018082.txt   1277435
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268477 | Film No.: 221402165
SIC: 7372 Services-Prepackaged Software